LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
SK-BR-3 A443654
10.0
uM
LJP6
0.2243 0.0239 -0.2950 0.1028
SK-BR-3 BMS345541
10.0
uM
LJP6
0.2242 0.0499 -0.2941 0.1216
BT-20 Mitoxantrone
10.0
uM
LJP5
0.1095 0.0433 -0.2905 0.0659
SK-BR-3 SNS-032
3.33
uM
LJP6
0.2289 0.0209 -0.2895 0.1107
SK-BR-3 Buparlisib
10.0
uM
LJP5
0.2276 0.0042 -0.2883 0.0825
SK-BR-3 Omipalisib
3.33
uM
LJP6
0.2294 0.0288 -0.2864 0.1054
BT-20 GSK1059615
10.0
uM
LJP6
0.1171 0.0213 -0.2806 0.0543
SK-BR-3 AZD7762
10.0
uM
LJP6
0.2313 0.0206 -0.2804 0.0770
SK-BR-3 Dasatinib
10.0
uM
LJP6
0.2314 0.0092 -0.2795 0.0621
SK-BR-3 Mitoxantrone
3.33
uM
LJP5
0.2312 0.0236 -0.2789 0.0639
SK-BR-3 AZD8055
10.0
uM
LJP6
0.2267 0.0609 -0.2789 0.0491
BT-20 GSK1059615
10.0
uM
LJP5
0.1179 0.0134 -0.2782 0.0279
SK-BR-3 SNS-032
1.11
uM
LJP6
0.2345 0.0114 -0.2781 0.0933
BT-20 Mitoxantrone
10.0
uM
LJP6
0.1224 0.0350 -0.2708 0.0425
SK-BR-3 Withaferin A
3.33
uM
LJP6
0.2372 0.0079 -0.2704 0.0661
SK-BR-3 CGP60474
1.11
uM
LJP6
0.2381 0.0153 -0.2699 0.0794
SK-BR-3 Alvocidib
0.37
uM
LJP6
0.2404 0.0493 -0.2699 0.1355
SK-BR-3 GSK1059615
3.33
uM
LJP5
0.2394 0.0186 -0.2693 0.0940
BT-20 AT-7519
10.0
uM
LJP6
0.1266 0.0285 -0.2673 0.0657
BT-20 AZD7762
10.0
uM
LJP6
0.1261 0.0137 -0.2671 0.0411
MCF7 CGP60474
10.0
uM
LJP6
0.0871 0.0183 -0.2670 0.0124
BT-20 CGP60474
3.33
uM
LJP6
0.1269 0.0278 -0.2668 0.0643
SK-BR-3 SNS-032
0.37
uM
LJP6
0.2437 0.0117 -0.2630 0.0935
SK-BR-3 A443654
3.33
uM
LJP6
0.2449 0.0232 -0.2599 0.0948
SK-BR-3 CGP60474
0.12
uM
LJP6
0.2446 0.0025 -0.2590 0.0723